T-cell trafficking, infiltration, killing
•
Antibodies directed against coinhibitory T-cell
receptors (TCR) or TGF-blocking drugs
E.g. PD-1 or PD-L1 antibodies (pembrolizumab, nivolumab)
Ribas, NEJM 2015
Herrera FG et al CA Cancer J Clin 2017